The combinatory application of CB-839 and the GLUT-1/-3 selective inhibitor Glutor led to the inhibition of cancer cell growth in HCT116 CRC cells, even under high glutamine and glucose conditions [190]. This evidence concerns the gene SLC2A1 and cancer.